Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Matthew Sweet

Vascular Surgery Seattle, WA Medical Doctor

NPI 1770766073 CMS profile 216128

University Of Washington Medical Ctr, 1959 Ne Pacific St., Bb-487, Box #356410, Seattle, WA 98195

Open in the dashboard

General payments

$28,326

105 records reported · program years 2019–2025

Research payments

$4,200

Paid to them · 8 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$479,175 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Matthew Sweet of Seattle, WA is reported in the CMS Open Payments database as having received $28,326 across 105 general payments and $4,200 in research payments paid to them. Separately, studies naming them as principal investigator received $479,175 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 87th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $554 5
2024 General $127 4
2024 Research $350 2
2023 General $2,000 8
2023 Research $700 1
2022 General $157 2
2021 General $8,848 33
2021 Research $700 1
2020 General $6,927 19
2020 Research $2,450 4
2019 General $9,714 34

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Sweet
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Matthew Sweet were reported at $554. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Matthew Sweet Vascular Surgery median Middle half National median
2019 $9,714 $796 $226–$2,363 $163
2020 $6,927 $348 $118–$1,110 $114
2021 $8,848 $471 $158–$1,421 $132
2022 $157 $725 $222–$2,183 $149
2023 $2,000 $836 $257–$2,440 $160
2024 $127 $909 $252–$2,619 $164
2025 $554 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic Vascular, Inc. $10,966 27 payments
  2. Medtronic, Inc. $5,562 12 payments
  3. Cook Medical LLC $3,457 27 payments
  4. CryoLife, Inc. $2,788 7 payments
  5. Cook Incorporated $2,095 2 payments
  6. W. L. Gore & Associates, Inc. $1,332 13 payments
  7. Endologix, Inc. $700 1 payment
  8. Boston Scientific Corporation $293 3 payments
  9. Shockwave Medical, Inc $266 1 payment
  10. Cook Research Incorporated $263 1 payment
  11. Other $603 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $15,081 13 payments
  2. Travel and Lodging $6,204 17 payments
  3. Food and Beverage $4,941 73 payments
  4. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $1,500 1 payment
  5. Honoraria $600 1 payment
Products named General payments · program years 2019–2025
  1. Endurant Aortic Stent Grafts $6,479 17 payments
  2. Endurant Aortic Stent Grafts $4,249 11 payments
  3. Cook Medical Zenith $1,606 3 payments
  4. Cook Medical Aortic Intervention $1,588 10 payments
  5. On-X $1,200 2 payments
  6. Zenith Alpha $1,127 7 payments
  7. E-nside TAAA $800 2 payments
  8. Zenith Spiral-Z $595 1 payment
  9. Product in Development $297 2 payments
  10. GORE TAG Conformable Thoracic Endoprosthesis $269 3 payments
  11. Other $3,181 43 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Terumo Medical Corporation $4,200 8 payments

Billing to Medicare

Part B · data year 2024 · 80 billing codes

Paid by Medicare

$65,852

Medicare's payments for the services billed

Medicare patients

280

Average age 73

Services billed

489

120 women, 160 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 44%
Arthritis 42%
Chronic kidney disease 41%
Heart failure 34%
Atrial fibrillation 33%
Diabetes 29%
Depression 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

113 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record